¤E¤Q¥|¦~«×¤º¬ì±M¬ìÂå®v¦Ò¸Õµ§¸ÕÃD -- ®ø¤Æ¬ì

(E) 1.Gastroesophageal reflux disease (GERD) ¬Û·í±`¨£¡A¨ä¦U¶µ¬ÛÃö±Ô­z¡A¦óªÌ¿ù»~¡H
A.ªø´Á«y¹ÂªÌÀ³ÃhºÃ¬O§_¦³GERD
B.­Y¯f±w¦³GERD¤§¯gª¬¡A¦ý¤ºµøÃè¬Ý¤£¥X­¹¹DÖß½¤¦³ÅܤơA24¤p®Éesophageal pH recording¦³§U©ó½T¥ß¶EÂ_
C.­Y¯f±w¦³GERD¤§¯gª¬¡A¦ý¤ºµøÃè¬Ý¤£¥X­¹¹DÖß½¤¦³ÅܤơA¥i°µ­¹¹D¤Á¤ù¡A¨ä¦ì¸mÀ³¦blower esophageal sphincter (LES) ¤W¤è5¤½¤À¥ª¥k
D.­Y¯f±w¦³GERD¤§¯gª¬¡A¨Ï¥Îproton pump inhibitor ( PPI) ªvÀø¤@¶g¦Ó¯gª¬¦³©ú Åã§ïµ½¡A¹ï¶EÂ_¤§½T¥ß¬Û·í¦³À°§U
E.­Y¯f±w¦³GERD¤§¯gª¬¡A¦ý¤ºµøÃè¬Ý¤£¥X­¹¹DÖß½¤¦³ÅܤơA±Ä¥ÎBernstein test¹ï¶EÂ_¨S¦³À°§U
 
(D) 2.Ãö©óZollinger-Ellison syndrome¤§±Ô­z¡A¤U¦C¦U¶µ¦óªÌ¿ù»~¡H
A.·í¼ìºÅ¥X²{©ó¤Q¤G«ü¸z²Ä¤G³¡¤À¥H¤U®É¡AÀ³¦Ò¼{¬O§_¦³gastrinoma
B.¦¹Ãþ¯f±w50%¥i¯à·|¦³¸¡Âm¯gª¬
C.Multiple Endocrine Neoplasia (MEN) type I ±wªÌ¬ù25%·|¦³gastrinoma
D.­G²G¤§»ÄÆP«×¡ABAO¡]°ò¦ª¬ºA¡^¡þMAO¡]ª`®gpentagastrin«á¡^< 0.6
E.Octreoscan¹ï©óprimary©Îmetastatic gastrinoma¤§°»´ú±Ó·P«×¬Ò¦³¤¤¤Wµ{«×¤§®Ä¯q
 
(B) 3.Ãö©ó¦å¤¤amylase¤§À³¥Î¡A¤U¦C±Ô­z¦óªÌ¿ù»~¡H
A.¹ï«æ©Ê¯ØŦª¢¤§¶EÂ_¡Aamylase¤§isoenzyme¡]¯S§O¬O P isoamylase¡^¸û¬°specific
B.¯ØŦ¬O°ß¤@§t¦³trypsinogen¤§¾¹©x¡A¦]¦¹¡A­Y¦å¤¤trypsinogen¼Æ­È²§±`¤É°ª¡A¤@©w¦³«æ©Ê¯ØŦª¢
C.¦³hypertriglyceridemiaªº¤H¡A¿©±w«æ©Ê¯ØŦª¢®É¡A¨ä¦å¤¤amylase¼Æ­È¥i¯à¥¿±`
D.Intestinal obstruction©Îinfarction¥ç¥i¯à¾É­P¦å¤¤amylase¼Æ­È²§±`¤É°ª
E.´ú¶q§¿¤¤ªºamylase¡A¦p¡Gamylase / creatinine clearance ratio¡A¨Ó¶EÂ_«æ©Ê¯ØŦª¢¡A¨äsensitivity¤Îspecificity¨Ã¤£¤ñ¦å¤¤amylase¼Æ­È§ó¦n
 
(A) 4.Ãö©ó¸¡Âm¡]diarrhea¡^¤§±Ô­z¡A¤U¦C¦U¶µ¦óªÌ¿ù»~¡H
A.Secretory diarrhea¤§¯SÂI¬°¡G¤ôª¬¡B¤j¶q¤§±Æ«K¡A³q±`µL¸¡µh¡A¥B©óªÅ¸¡«á§Y·|°±¤î
B.Enterotoxin¾É­P¤§¸¡Âm¡A±wªÌ³q±`¤£·|µo¿N
C.Preformed toxin¤Þ°_¤§¸¡Âm¡A¼ç¥ñ´Á³Ìµu¡A¬ù¬°8-24¤p®É
D.«æ©Ê¸¡Âm90%¥H¤W«Y¥Ñinfectious agents©Ò¤Þ°_¡FºC©Ê¸¡Âm«h¦h¥Ñ«D·P¬V©Ê­ì¦]©Ò¾É­P
E.Pseudodiarrhea«Y«ü±Æ«K¦¸¼Æ¼W¥[¡A¦ý¨C¦¸±Æ«Kªº¶q¤£¦h¡]< 200 g/day¡^¡A³oºØ±¡§Î±`¦ñÀHirritable bowel syndrome©Îproctitisµ¥¨zªùªþªñ¤§¯fªp
 
(B) 5.Ãö©óIrritable Bowel Syndrome¡]IBS¡^¤§±Ô­z¡A¤U¦C¦U¶µ¦óªÌ¿ù»~¡H
A.IBS¦³¨âºØ¥D­nÃþ«¬¡A¤@ºØ¥H¸¡Âm¬°¥D­nªí²{¡A¥t¤@ºØ«h¬°«K¯µ©M¸¡Âm¥æ´À¥X²{
B.¦¹Ãþ¯f±w·|¦³¸¡µh©Î¸¡³¡¤£¾A¡A¸¡µhµo¥Í³¡¦ì±`«]­­©ó¤W¸¡³¡
C.¦¹Ãþ¯f±w¤§¸¡µh³q±`©ó±Æ«K«á·|¸Ñ°£
D.¸¡µh¤§µo§@±`»P±Æ«KÀW²v¡]stool frequency¡^¤§§ïÅܦ³Ãö
E.¸¡µh¤§µo§@±`»P¤j«K©Ê½è¡]stool form¡^¤§§ïÅܦ³Ãö
 
(C) 6.¹ï©óÃhºÃ¦³intestinal obstruction¤§±wªÌ¡A¸¡³¡¢æ¥ú·Ó¬Û¡]plain abdomen¡^¥i´£¨Ñ¬Û·í¦³¥Îªº¸ê®Æ¡C¤U¦C¦U¶µ±Ô­z¡A¦óªÌ¿ù»~¡H
A.Plain abdomen¥Î¨Ó§PÂ_nonstrangulating complete small-bowel obstruction¬Û·í¥i¾a
B.Partial mechanical small-bowel obstruction»Padynamic ileus¤£¤Ó®e©ö°Ï¤À¡A¦ýcolonic distension¦badynamic ileus³q±`¸û©úÅã
C.µÈ¤jªº¤p¸z¤¤¥i¨£air-fluid levels¡A±`±Æ¦C¦¨¡§stepladder¡¨ pattern¡A¤Ö¨£¤º§tªÅ®ðªº¤j¸z¡A³o¨Çµo²{±`¨£©óstrangulating small-bowel obstruction
D.­YÁ{§É¯gª¬«Ü¹³small intestine obstruction¡A¦ýplain abdomen¬Ý°_¨Ó¥¿±`¡A¦¹®É¦w±Æ¸¡³¡CTÀˬd¦³§U©ó¶EÂ_
E.³Ü¾X¾¯¨ÓÀ°¦£§PÂ_¤p¸zªºªý¶ë³¡¦ì¬O¬Û·í¦w¥þªº
 
(C) 7.Ãö©óºC©ÊC«¬¨xª¢¤§ªvÀø¡A¤U¦C±Ô­z¦óªÌ¿ù»~¡H
A.Interferon £\ ¦X¨ÖRibavirin¤§²Õ¦XÀøªk¬O¥Ø«e¨Ï¥Îªº¥D­n¤è¦¡
B.²Õ¦XÀøªk¹ïHCV genotype 2/3¤§®ÄªGÀu©ó¹ïgenotype 1¤§®ÄªG
C.Ribavirin¤£¥i¥Î©ó¦³«aª¬°Ê¯ß¤ßŦ¯f±wªÌ¡A¦ý¥i¥Î©óµÇ¥\¯à¤£¥þ¤§±wªÌ
D.ºC©ÊC«¬¨xª¢±wªÌ¤w¥X²{¨x¥\¯à¤£¥þ¡]decompensation¡^®É¡A¤£¾A¥Î²Õ¦XÀøªk
E.¦å¤pªO¤Î¥Õ¦å²y¼Æ¥Ø­°§C¬OInterferon £\ ±`¨£ªº°Æ§@¥Î
 
(B) 8.¤U¦C¦UºØ¯e¯f¡A¦b¤fµÄ¤º¡B¥~¥i¯à·|¦³¯f¨_¡C½Ð°Ý¨ä¤¤¨º¤@­Ó¯e¯fªº±wªÌ¡A¨ä¥þ¨­¥Ö½§¤W¤]·|¦³¼sªxªº¦â¯À¨HµÛ¡H
A.Leukoplakia
B.Addison's disease
C.Osler-Rendu-Weber syndrome ( Hereditary Telangiectasia )
D.Heavy metal pigmentation
E.Peutz-Jeghers syndrome
 
(D) 9.¤@¦ì¯f¤H¦]¶À¯n¦í°|¡A¤§«e±qµL¥k¤W¸¡µhªº¯f¥v¡A¨­Åé¶E¹î®ÉºN¨ìµÈ¤jªºÁxÅn¡C¤U¦C¦óªÌ³Ì²Å¦X¦¹µ¥¯f±¡¡H
A.Impaction of distal CBD stone
B.Compression of common hepatic duct
C.Pancreatic neck cancer
D.Papilla vater cancer
E.Intrahepatic stone
 
(C) 10.¤@¦ìºC©ÊB«¬¨xª¢¤§±wªÌ¦í°|¡A¨ä©â¦åÀËÅ礧µ²ªG¦p¤U¡GBilirubin(T)/(D)=2.8/2.2¡]<=1.0/<=0.4¡^mg/dL¡AGOT=430¡]<37¡^¡AGPT= 410¡]<41¡^¡AAlkalinephosphatase=720¡]<=220¡^¡A£^-GT=420¡]<=50¡^¡C½Ð°Ý¤U¦C¦óªÌ¥¿½T¡H1. ³o¦ì¯f¤H¤w¸g¥X²{¨x¥\¯à°I°h¡]decompensation¡^ªº±¡ªp¡C2. ³o¦ì¯f¤H¤§¯f±¡²Å¦XºC©ÊB«¬¨xª¢«æ©Êµo§@¡]acute exacerbation¡^¡C3. Prothrombin time¤§ÀËÅç¬O¦³¥²­nªº¡C4. À³°¨¤W¦w±Æ¸¡³¡¶W­µªiÀˬd¡C5. À³¥J²Ó¸ß°Ý¨ä³Ìªñ¬O§_¦³¥k¤W¸¡µh¡C
A.1 + 2 + 3
B.2 + 3 + 4
C.3 + 4 + 5
D.4 + 5 + 1
E.5 + 1 + 2
 
(E) 11.Ãö©ó«DÃþ©T¾J§Üµoª¢ßÓª«¡]NSAID¡^¾É­Pªº­G¸z¹D¨Öµo¯g¡A¤U¦C±Ô­z¦óªÌ¿ù»~¡H1. ÄY­«ªºNSAID¾É­Pªº¨Öµo¯g¡A¤j¦h¼Æ¯f±w©ó¿©¯f«eÀ³¦³dyspepsia¡C2. §C¾¯¶q¡]<=75 mg/d¡^Aspirin¤£·|¾É­PÄY­«ªº¨Öµo¯g¡C3. ¦~¬ö¤j¡A¹L¥h¦³®ø¤Æ©Ê¼ìºÅ¡A¦P®ÉªA¥Î§tÃþ©T¾J¤§ßÓª«¡A¬Ò¬Oestablished risk factor¡C4. ­Y¦³risk factor¦Ó¤´»ÝªA¥ÎNSAID¡A¥i¥Hproton pump inhibitors©Îmisoprostol¹w¨¾­G¸z¹D¨Öµo¯g¡C5. ­YNSAID¤w³y¦¨­G¼ìºÅ¡A¦ý¤S¤£¯à°±¥Î¡A¥i¥ÎH2 blockerªvÀø¡C
A.1 + 3 + 5
B.1 + 2 + 4
C.2 + 3 + 4
D.3 + 4 + 5
E.1 + 2 + 5
 
(E) 12.¤U¦C¦³Ãö¸zô½¤´`Àô»Ùꤧ±Ô­z¡A¦óªÌ¦³»~¡H
A.Arterial embolus»PºC©Êatrial fibrillation¦³Ãö
B.Arterial thrombosis»Patherosclerosis¦³Ãö
C.Venous occlusion»Poral contraceptives¦³Ãö
D.Non-occlusive ischemia»Phypotension¦³Ãö
E.Abdominal angina»PªÅ¸¡¸¡µh¦³Ãö
 
(B) 13.¤U¦C¦³Ãö·P¬V©Ê­¹¹Dª¢¤§±Ô­z¡A¦óªÌ¬°»~¡H
A.³æ¯Â¯p¯l¯f¬r­¹¹Dª¢¦b»ó¤Î¼L®B±`¦³úO¯l
B.±aª¬¯p¯l¯f¬r­¹¹Dª¢©öµo¥Í©ó¿é¦å±wªÌ
C.¥¨²Ó­M¯f¬r­¹¹Dª¢¶}©l®É¼ìºÅ¬O°Ë¦æ©Ê¡]serpiginous¡^
D.HIV­¹¹Dª¢¦p¦³²`¼s¼ìºÅ¡A¶·¥ÎÃþ©T¾JªvÀø
E.©À¯]µß­¹¹Dª¢¦³¦hµo©Ê¶À¦â¬ð°_ªº´³¶ô
 
(D) 14.¤Q¤G«ü¸z¼ìºÅ±wªÌ¤§¯f²z¥Í²z¾Ç¤W¤§±Ô­z¡A¦óªÌ¦³»~¡H
A.©]¶¡¤Àªc­G»Ä¼W¥[
B.¤Q¤G«ü¸z HCO3- ¤Àªc´î¤Ö
C.¤é¶¡­G»Ä¤Àªc¼W¥[
D.­G¿E¯À±Ó·P©Ê­°§C
E.¶º«á­G¿E¯ÀÄÀ©ñ¼W¥[
 
(D) 15.¤U¦C¯e¯f¡A¦óªÌ¨äSerum-ascites albumin concentration gradient¤p©ó1.1 g/dL¡H
A.Cirrhosis
B.Congestive heart failure
C.Massive hepatic metastasis
D.Nephrotic syndrome
E.Acute fatty liver of pregnancy
 
(E) 16.­¹¹D¹B°Ê§ÎºAÅã¥Ü¥­·Æ¦Ù³¡¥÷¥¿±`¦Ó°©Àf¦Ù³¡¥÷¦¬ÁYÀ£´T«×­°§C¡A¨ä¥i¯à¶EÂ_¬°¡G
A.Viral esophagitis
B.Scleroderma
C.Achalasia
D.Diffuse esophageal spasm
E.Pharyngeal paralysis
 
(A) 17.Whipple's disease (intestinal lipodystrophy ) ¤§±Ô­z¡A¦óªÌ¬°»~¡H
A.¬°¿ò¶Ç©Ê¯e¯f¡A¦nµo©ó¤¤¦~¥Õ¤H¨k©Ê
B.ªø´Á¸¡Âm¡AÀç¾i¤£¨}
C.¦³¦hµo©ÊÃö¸`ª¢
D.¦³¤¤¼Ï¯«¸g¯gª¬¡A¦pÀYµh¡B½Æµø
E.ªvÀø¨Ï¥Î§Ü¥Í¯À
 
(E) 18.¤U¦CßÓª«¡A¦óªÌÀ³¤£·|¨Öµo«æ©Ê¯ØŦª¢¡H
A.Azathioprine
B.Sulfonamides
C.Thiazide diuretics
D.Tetracycline
E.Anticholinergics
 
(E) 19.¤U¦C±¡ªp¦p¦X¨Ö¨Ï¥ÎNSAIDs¡A¥i¯à»¤µo­G¤Q¤G«ü¸z¼ìºÅ¡A°£¤F
A.¦~¦Ñ
B.¨Ï¥ÎGlucocorticoids
C.¨Ï¥Î¦hºØNSAIDs
D.¨Ï¥ÎAnticoagulants
E.¨Ï¥ÎProstaglandin
 
(E) 20.¤U¦C¬°Zollinger-Ellison syndrome¤§¼v¹³Àˬd¤¤¡A±Ó·P«×³Ì°ªªº¬O
A.¶W­µªi
B.CT Scan
C.Selective angiography
D.MRI
E.Endoscopic ultrasonography
 
(B) 21.¤U¦CÁx¹Dµ²¥Û¤§§Î¦¨¦]¯À¡A¦óªÌ¬°¦â¯Àµ²¥Û¤§¦¨¦]¡H1. Prolonged parenteral nutrition.2. Chronic hemolysis.3. Alcoholic cirrhosis.4. Chronic biliary tract infection.5. Fasting.
A.1 + 2 + 3
B.2 + 3 + 4
C.3 + 4 + 5
D.1 + 3 + 4
E.2 + 4 + 5
 
(E) 22.¤U¦C¦³ÃößÓª«¤Þ°_¨x¯f¤§±Ô­z¡A¦óªÌ¬°«D¡H1. Acetaminophen¹L¶q¤§ªvÀø¡A¨Ï¥ÎN-acetylcysteine¡C2. Amiodarone¥iµo¥ÍÃþ¦ü¯f¬r©Ê¨xª¢¯f²zÅܤơC3. Phenytoin ¥iµo¥Ísteatohepatitis¡C4. INH¨Ö¥ÎRifampicin¡A¨x¬r©Ê¼W¥[¡C5. Oral contraceptives¥iµo¥Ícholestasis¤Îportal inflammation¡C
A.1 + 2 + 3
B.2 + 3 + 4
C.3 + 4 + 5
D.1 + 3 + 5
E.2 + 3 + 5
 


< ¤E¤Q¥|¦~«×¸ÕÃD¥Ø¿ý >